NATCOPHARM.BONATCOPHARM.BOBSE
Loading
Revenue ScalingExpanding
Percentile Rank100
3Y CAGR+31.6%
5Y CAGR+18.3%
Studio
Year-over-Year Change

Total revenue from sales of goods and services

3Y CAGR
+31.6%/yr
vs -2.8%/yr prior
5Y CAGR
+18.3%/yr
Recent acceleration
Acceleration
+34.4pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$44.32B+10.7%
2024$40.02B+47.8%
2023$27.09B+39.2%
2022$19.46B-5.3%
2021$20.56B+7.4%
2020$19.15B-8.6%
2019$20.95B-4.1%
2018$21.85B+8.1%
2017$20.20B+93.8%
2016$10.42B-